BRIEF published on 08/27/2024 at 13:18, 2 months 28 days ago Britvic Shareholders Approve Acquisition by Carlsberg UK Holdings Acquisition Shareholders Resolution Britvic Carlsberg
PRESS RELEASE published on 08/27/2024 at 13:13, 2 months 28 days ago Results of Shareholder Meetings Britvic plc announces successful shareholder meetings approving cash acquisition by Carlsberg UK Holdings Limited. Completion subject to conditions Britvic Plc Shareholder Meetings Cash Acquisition Carlsberg UK Holdings Limited Scheme Approval
BRIEF published on 08/26/2024 at 14:52, 2 months 29 days ago The Vanguard Group, Inc. Declares Britvic PLC Securities Position Britvic Plc Financial Reporting Takeover Code Securities Disclosure Vanguard Group
PRESS RELEASE published on 08/26/2024 at 14:47, 2 months 29 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic PLC The Vanguard Group, Inc. discloses 5.48% stake in Britvic PLC through 13,628,741 ordinary shares. Dealings include purchase and sale of securities Ordinary Shares The Vanguard Group, Inc. Britvic Plc Stake Disclosure Dealings
BRIEF published on 08/23/2024 at 15:29, 3 months 1 day ago Vanguard Group Discloses Significant Stake in Britvic Plc Ordinary Shares Takeover Code Stake Disclosure Vanguard Britvic
PRESS RELEASE published on 08/23/2024 at 15:24, 3 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.48% ownership in Britvic plc in a Form 8.3 filing Securities Form 8.3 Britvic Plc Vanguard Group Ownership Disclosure
BRIEF published on 08/20/2024 at 15:22, 3 months 4 days ago The Vanguard Group Discloses Significant Stake in Britvic plc Securities Takeover Code Stake Disclosure Vanguard Britvic
PRESS RELEASE published on 08/20/2024 at 15:17, 3 months 4 days ago Form 8.3 - The Vanguard Group, Inc.: Britvic plc The Vanguard Group, Inc. discloses 5.47% ownership of Britvic plc securities on 19 August 2024 as per Form 8.3 filing Securities The Vanguard Group, Inc. Form 8.3 Britvic Plc Ownership Disclosure
BRIEF published on 08/20/2024 at 12:45, 3 months 4 days ago Britvic Announces Director Share Purchases Share Incentive Plan Director Shareholding Stock Exchange Executive Directors Britvic
PRESS RELEASE published on 08/20/2024 at 12:40, 3 months 4 days ago Director/PDMR Shareholding Britvic plc notified of Director/PDMR Shareholding transactions under Britvic Share Incentive Plan. Directors Simon Litherland and Rebecca Napier purchased Shares and Matching Shares Transactions Share Incentive Plan Britvic Plc Shareholding Director
Published on 11/25/2024 at 04:00, 4 hours 30 minutes ago Tanzania Safaris Unveils New Luxury Adventure Packages for 2025
Published on 11/22/2024 at 23:55, 2 days 8 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 9 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 9 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/25/2024 at 08:15, 15 minutes ago EQS-Adhoc: Airbus SE: Airbus launches second tranche of previously-announced limited share buyback programme
Published on 11/25/2024 at 08:00, 30 minutes ago Dalata Hotel Group PLC: POS-Transaction in Own Shares
Published on 11/24/2024 at 19:16, 13 hours 14 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/25/2024 at 08:00, 30 minutes ago EURAZEO RAISES A €180 MILLION CONTINUATION FUND TO SUPPORT I-TRACING AND ITS MANAGEMENT TEAM IN THE NEXT PHASE OF GROWTH
Published on 11/21/2024 at 06:58, 4 days 1 hour ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 14 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
